EFFECT OF WEIGHT-LOSS ON BLOOD-PRESSURE AND INSULIN-RESISTANCE IN NORMOTENSIVE AND HYPERTENSIVE OBESE INDIVIDUALS

Citation
Hy. Su et al., EFFECT OF WEIGHT-LOSS ON BLOOD-PRESSURE AND INSULIN-RESISTANCE IN NORMOTENSIVE AND HYPERTENSIVE OBESE INDIVIDUALS, American journal of hypertension, 8(11), 1995, pp. 1067-1071
Citations number
NO
Categorie Soggetti
Cardiac & Cardiovascular System
ISSN journal
08957061
Volume
8
Issue
11
Year of publication
1995
Pages
1067 - 1071
Database
ISI
SICI code
0895-7061(1995)8:11<1067:EOWOBA>2.0.ZU;2-R
Abstract
In this study, the effect of weight loss on blood pressure and various facets of glucose and insulin metabolism was examined in 22 subjects with mild to moderate obesity; 11 with high blood pressure (diastolic blood pressure >95 mm Hg) and 11 with normal blood pressure (diastolic blood pressure <90 mm Hg). The two groups were similar in mean (+/-SE M) body mass index at baseline (30.2 +/- 1.0 v 31.6 +/- 1.1 kg/m(2)), and each group lost approximately 8 kg during the 3-month study period . Blood pressure fell significantly (P < .003) following the 8 kg weig ht loss in both the normotensive (122 +/- 3/81 +/- 3 to 110 +/- 3/74 /- 2 mm Hg) and hypertensive (149 +/- 3/98 +/- 1 to 135 +/- 3/86 mm Hg ) subjects. Furthermore, the plasma glucose and insulin responses to a 75 g oral glucose load were significantly lower (P < .001) following weight loss. Finally, insulin resistance, as assessed by determining t he steady-state plasma glucose (SSPG) concentration at the end of a 18 0 min infusion of somatostatin, insulin, and glucose, was also lower ( P < .002) after the 8 kg weight loss in the normotensive (243 +/- 23 t o 172 +/- 15 mg/dL) and hypertensive subjects (266 +/- 18 to 181 +/- 2 5 mg/dL). Since the steady-state plasma insulin concentrations were, i f anything, slightly lower after weight loss in both groups, the lower post-weight loss SSPG values actually underestimate the improvement o f insulin resistance. Thus, weight loss of 8 kg in moderately obese in dividuals leads to significant decreases in blood pressure and plasma glucose and insulin concentrations in response to an oral glucose chal lenge and degree of insulin resistance.